Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TEN | Ann: TENON DELISTS FROM NZX | 31/07/17 | 0 | 585 | |||
|
|||||||
TEN | Ann: SPH Notice - Salt Funds Management Limited | 14/07/17 | 0 | 651 | |||
|
|||||||
TEN | Ann: SPH Notice - Third Avenue Management LLC | 13/07/17 | 0 | 670 | |||
|
|||||||
TEN | Ann: Tenon Limited (“TEN”) – Delisting | 05/07/17 | 0 | 681 | |||
|
|||||||
TEN | Ann: Tenon Provides Update | 05/07/17 | 0 | 747 | |||
|
|||||||
TEN | Ann: Ongoing Disclosure Notices | 04/05/17 | 0 | 648 | |||
|
|||||||
TEN | Ann: TENON CLOSES SALE OF CLEARWOOD BUSINESS | 09:18 | 0 | 721 | |||
|
|||||||
TEN | Ann: TEN - Capital Reconstruction, Amended Dates | 19/04/17 | 0 | 661 | |||
|
See All Discussions